Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery
SJ Connolly,
AS Mulji,
DL Hoffert,
C Davis,
and
BW Shragge
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Fourteen patients with atrial fibrillation or flutter and a ventricular rate of greater than or equal to 120 beats/min occurring after cardiac surgery entered a double-blind placebo-controlled conditional crossover trial of intravenous propafenone. Patients randomly received either propafenone (2 mg/kg body weight) or placebo during a 10 minute intravenous infusion. If 20 minutes after the initiation of this infusion there was no conversion to sinus rhythm, the patient received a second intravenous infusion over 10 minutes (either propafenone or placebo, whichever was not given first). The electrocardiogram was recorded continuously throughout the study. Fourteen patients received propafenone and 10 received placebo. No patient's rhythm converted to sinus rhythm after placebo. In six patients (43%) (p less than 0.001), the arrhythmia converted to sinus rhythm between 5 and 10 minutes after the end of the propafenone infusion. After propafenone, the ventricular response to atrial fibrillation or flutter decreased significantly from 141.6 +/- 15.2 to 116.0 +/- 15.5 beats/min. Ventricular rate did not change after placebo. The mean propafenone plasma concentration was 3.46 +/- 2.17 mg/liter. The only side effect of propafenone noted was a decrease in systolic blood pressure of 9 +/- 9 mm Hg. Propafenone was useful for management of atrial fibrillation after cardiac surgery both for control of rapid ventricular response and for conversion to sinus rhythm.
This article has been cited by other articles:
|
|
|
|
 
J. Dunning, T. Treasure, M. Versteegh, S. A. M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
Eur J Cardiothorac Surg,
December 1, 2006;
30(6):
852 - 872.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Martinez, E. B. Bass, and P. Zimetbaum
Pharmacologic Control of Rhythm: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest,
August 1, 2005;
128(2_suppl):
48S - 55S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Martinez, A. E. Epstein, and E. B. Bass
Pharmacologic Control of Ventricular Rate: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest,
August 1, 2005;
128(2_suppl):
56S - 60S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Maisel, J. D. Rawn, and W. G. Stevenson
Atrial Fibrillation after Cardiac Surgery
Ann Intern Med,
December 18, 2001;
135(12):
1061 - 1073.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Cogolludo, F. Perez-Vizcaino, G. Lopez-Lopez, M. Ibarra, F. Zaragoza-Arnaez, and J. Tamargo
Propafenone Modulates Potassium Channel Activities of Vascular Smooth Muscle from Rat Portal Veins
J. Pharmacol. Exp. Ther.,
November 1, 2001;
299(2):
801 - 810.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Valderrabano and B. N. Singh
Review : Electrophysiologic and Antiarrhythmic Effects of Propafenone: Focus on Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1999;
4(3):
183 - 198.
[PDF]
|
|
|
|
|
|
|
B. N. Singh, B. Lopez, and J. S.M. Sarma
Significance and Prevention of Atrial Fibrillation Occurring After Cardiac Surgery: A Time for Fundamental Change in Strategy?
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1998;
3(3):
259 - 267.
[PDF]
|
|
|
|
|
|
|
A. Serdar Fak, H. Tezcan, O. Caymaz, S. Tokay, S. Oktay, and A. Oktay
Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1997;
2(4):
251 - 257.
[Abstract]
[PDF]
|
|
|
|
